Please assess the completion status of the following clinical trial:

Trial Title: Pramipexole and Morphine for Renal Colic

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 19 - 65~* ED presentation with pain associated with suspected renal colic~* Patient reported failure to achieve pain relief with NSAID treatment in ED (additional pain treatment needed per treatment team)~Exclusion Criteria:~* Age \< 19 or ≥ 66~* Allergy to any study medication~* Known pregnancy or breastfeeding~* Received opioid prior to enrollment~* Received IV Lidocaine during current ED visit~* Known chronic renal disease~* Currently taking any dopamine receptor agonist or antagonists (Do I need to list?)~* Unable to consent

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 66 Years
- Healthy Volunteers: f

Study Arms:
- Pramipexole and half-standard dose of morphine (Type: EXPERIMENTAL): 0.25 mg oral tablet of pramipexole in combination with 0.05mg/kg of IV morphine
- Standard dose of morphine and placebo (Type: ACTIVE_COMPARATOR): 0.1mg/kg of IV morphine in combination with a placebo pill

Based on this trial design, predict the completion outcome and termination type (if applicable).